Cargando…

The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases

PURPOSE: The first aim of this study was to compare the intratumoral and peritumoral blood flow parameters in glioblastomas and brain metastases measured by pseudocontinuous arterial spin labeling MRI (3D pCASL). The second aim of this study was to determine whether pCASL could aid in identifying th...

Descripción completa

Detalles Bibliográficos
Autores principales: Solozhentseva, Kristina, Batalov, Artem, Zakharova, Natalia, Goryaynov, Sergey, Pogosbekyan, Eduard, Pronin, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086561/
https://www.ncbi.nlm.nih.gov/pubmed/35558515
http://dx.doi.org/10.3389/fonc.2022.874924
_version_ 1784704030521425920
author Solozhentseva, Kristina
Batalov, Artem
Zakharova, Natalia
Goryaynov, Sergey
Pogosbekyan, Eduard
Pronin, Igor
author_facet Solozhentseva, Kristina
Batalov, Artem
Zakharova, Natalia
Goryaynov, Sergey
Pogosbekyan, Eduard
Pronin, Igor
author_sort Solozhentseva, Kristina
collection PubMed
description PURPOSE: The first aim of this study was to compare the intratumoral and peritumoral blood flow parameters in glioblastomas and brain metastases measured by pseudocontinuous arterial spin labeling MRI (3D pCASL). The second aim of this study was to determine whether pCASL could aid in identifying the source of brain metastases. MATERIALS AND METHODS: This study included 173 patients aged 12 to 83 years (median age—61 years), who were observed at the National Medical Research Center for Neurosurgery. All patients underwent preoperative MRI with pCASL perfusion. Thereafter patients were operated on and received histological diagnosis. No patients received preoperative chemo or radiotherapy. RESULTS: The values of maximum and normalized intratumoral blood flow were significantly higher in the group with gliblastoma than in the group with brain metastases: 168.98 + −91.96 versus 152.1 + −173.32 and 7.6 + −8.4 versus 9.3 + −5.33 respectively (p <0.01). However, ROC analysis showed low AUC specificity and sensitivity (0.64, 70%, 60% for mTBF and 0.66, 77%, 62% for nTBF). Peritumoral blood flow parameters were also higher in the glioblastoma group (29.61 + −22.89 versus 16.58 + −6.46 for mTBF and 1.63 + −1.14 versus 0.88 + −0.38 for nTBF, respectively; p <0.01). ROC analysis showed the following measurements of AUC, specificity, and sensitivity (0.75, 68%, 73% for mTBF and 0.77, 58%, 91% for nTBF). Regarding pCASL and various histological subsets of brain metastases, the study found statistically significant differences between the lung and melanoma metastases and the lung and kidney metastases. ROC analysis gave the following values for lung and melanoma metastases: AUC—0.76, specificity—75%, and sensitivity—73% for mTBF; 0.83, 67%, and 93% respectively, for nTBF. For lung and kidney metastases: AUC—0.74, specificity—70%, and sensitivity—93% for mTBF; 0.75, 70%, and 93% respectively, for nTBF. CONCLUSIONS: pCASL could aid in differential diagnosis between glioblastoma and brain metastases. Measurement of peritumoral blood flow demonstrates higher specificity and sensitivity than with intratumoral blood flow. Moreover, pCASL provides the ability to distinguish lung metastases from kidney and melanoma metastases.
format Online
Article
Text
id pubmed-9086561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90865612022-05-11 The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases Solozhentseva, Kristina Batalov, Artem Zakharova, Natalia Goryaynov, Sergey Pogosbekyan, Eduard Pronin, Igor Front Oncol Oncology PURPOSE: The first aim of this study was to compare the intratumoral and peritumoral blood flow parameters in glioblastomas and brain metastases measured by pseudocontinuous arterial spin labeling MRI (3D pCASL). The second aim of this study was to determine whether pCASL could aid in identifying the source of brain metastases. MATERIALS AND METHODS: This study included 173 patients aged 12 to 83 years (median age—61 years), who were observed at the National Medical Research Center for Neurosurgery. All patients underwent preoperative MRI with pCASL perfusion. Thereafter patients were operated on and received histological diagnosis. No patients received preoperative chemo or radiotherapy. RESULTS: The values of maximum and normalized intratumoral blood flow were significantly higher in the group with gliblastoma than in the group with brain metastases: 168.98 + −91.96 versus 152.1 + −173.32 and 7.6 + −8.4 versus 9.3 + −5.33 respectively (p <0.01). However, ROC analysis showed low AUC specificity and sensitivity (0.64, 70%, 60% for mTBF and 0.66, 77%, 62% for nTBF). Peritumoral blood flow parameters were also higher in the glioblastoma group (29.61 + −22.89 versus 16.58 + −6.46 for mTBF and 1.63 + −1.14 versus 0.88 + −0.38 for nTBF, respectively; p <0.01). ROC analysis showed the following measurements of AUC, specificity, and sensitivity (0.75, 68%, 73% for mTBF and 0.77, 58%, 91% for nTBF). Regarding pCASL and various histological subsets of brain metastases, the study found statistically significant differences between the lung and melanoma metastases and the lung and kidney metastases. ROC analysis gave the following values for lung and melanoma metastases: AUC—0.76, specificity—75%, and sensitivity—73% for mTBF; 0.83, 67%, and 93% respectively, for nTBF. For lung and kidney metastases: AUC—0.74, specificity—70%, and sensitivity—93% for mTBF; 0.75, 70%, and 93% respectively, for nTBF. CONCLUSIONS: pCASL could aid in differential diagnosis between glioblastoma and brain metastases. Measurement of peritumoral blood flow demonstrates higher specificity and sensitivity than with intratumoral blood flow. Moreover, pCASL provides the ability to distinguish lung metastases from kidney and melanoma metastases. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9086561/ /pubmed/35558515 http://dx.doi.org/10.3389/fonc.2022.874924 Text en Copyright © 2022 Solozhentseva, Batalov, Zakharova, Goryaynov, Pogosbekyan and Pronin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Solozhentseva, Kristina
Batalov, Artem
Zakharova, Natalia
Goryaynov, Sergey
Pogosbekyan, Eduard
Pronin, Igor
The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases
title The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases
title_full The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases
title_fullStr The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases
title_full_unstemmed The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases
title_short The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases
title_sort role of 3d-pcasl mri in the differential diagnosis of glioblastoma and brain metastases
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086561/
https://www.ncbi.nlm.nih.gov/pubmed/35558515
http://dx.doi.org/10.3389/fonc.2022.874924
work_keys_str_mv AT solozhentsevakristina theroleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT batalovartem theroleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT zakharovanatalia theroleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT goryaynovsergey theroleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT pogosbekyaneduard theroleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT proninigor theroleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT solozhentsevakristina roleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT batalovartem roleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT zakharovanatalia roleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT goryaynovsergey roleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT pogosbekyaneduard roleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases
AT proninigor roleof3dpcaslmriinthedifferentialdiagnosisofglioblastomaandbrainmetastases